Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia
暂无分享,去创建一个
M. Fini | M. Moskowitz | E. Lo | Xiaoying Wang | Tatsuro Mori | Jae‐Chang Jung | T. Sumii | M. Asahi | M. E. Fini | M. A. Moskowitz
[1] A. Gearing,et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures , 2001, Brain Research.
[2] M. Fini,et al. Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] P. Gottschall,et al. Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid , 2000, Neuroscience Letters.
[4] P. Lapchak,et al. Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke , 2000, Stroke.
[5] M. Fini,et al. Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury , 2000, The Journal of Neuroscience.
[6] S. Traynelis,et al. Serine proteases and brain damage – is there a link? , 2000, Trends in Neurosciences.
[7] T. Ferguson,et al. MMP-2 and MMP-9 Increase the Neurite-Promoting Potential of Schwann Cell Basal Laminae and Are Upregulated in Degenerated Nerve , 2000, Molecular and Cellular Neuroscience.
[8] T. Betsuyaku,et al. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. , 2000, The American journal of pathology.
[9] H. Hartung,et al. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system , 2000, Journal of Neuroimmunology.
[10] V. Yong,et al. Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo , 2000, Journal of neuroscience research.
[11] J. Mcculloch,et al. Quantitative Assessment of Ischemic Pathology in Axons, Oligodendrocytes, and Neurons: Attenuation of Damage after Transient Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] G. Davies-Jones,et al. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. , 2000, Brain : a journal of neurology.
[13] E. Lo,et al. Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] M. Fujimura,et al. Overexpression of Copper and Zinc Superoxide Dismutase in Transgenic Mice Prevents the Induction and Activation of Matrix Metalloproteinases after Cold Injury-Induced Brain Trauma , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] T. Hibi,et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation , 2000, Bone Marrow Transplantation.
[16] J. Wettstein,et al. White matter ischaemia , 1999, Brain Research Reviews.
[17] K. Frei,et al. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. , 1999, Journal of cell science.
[18] Z. Werb,et al. Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.
[19] M. Fujimura,et al. Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] M. Chopp,et al. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice , 1999, Brain Research.
[21] T. Seifert,et al. Differential expression of matrix metalloproteinases in bacterial meningitis. , 1999, Brain : a journal of neurology.
[22] J. Koziol,et al. Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] D. Ribatti,et al. Developmental expression of ZO-1 antigen in the mouse blood-brain barrier. , 1999, Brain research. Developmental brain research.
[24] J. Westermarck,et al. Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] K. Hossmann,et al. Regional Metabolic Disturbances and Cerebrovascular Anatomy after Permanent Middle Cerebral Artery Occlusion in C57Black/6 and SV129 Mice , 1999, Neurobiology of Disease.
[26] J B Schulz,et al. Caspases as treatment targets in stroke and neurodegenerative diseases , 1999, Annals of neurology.
[27] M. Cuzner,et al. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.
[28] G. Rosenberg,et al. Matrix Metalloproteinases in Cerebrovascular Disease , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] Z. Werb,et al. ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.
[30] G. Rosenberg,et al. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.
[31] G. Rosenberg,et al. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[32] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[33] F. Barone,et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. , 1998, Stroke.
[34] Voon Wee Yong,et al. Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.
[35] S. Lipton,et al. Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.
[36] H. E. Wart,et al. Substrate Specificity and Mechanisms of Substrate Recognition of the Matrix Metalloproteinases , 1998 .
[37] M. Fini,et al. Regulation of Matrix Metalloproteinase Gene Expression , 1998 .
[38] S. Nigam,et al. Molecular structure and assembly of the tight junction. , 1998, American journal of physiology. Renal physiology.
[39] S. Strickland,et al. Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin , 1997, Cell.
[40] L. Houenou,et al. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system , 1997, Brain Research Reviews.
[41] S. Tsirka,et al. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Rosenberg,et al. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat , 1997, Neurology.
[43] S. Tsirka,et al. An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus , 1997, The Journal of Neuroscience.
[44] Gary A. Rosenberg,et al. Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] A. Dayton. The Rev Axis of HIV-1 and Its Associated Host Cofactors: A Viral Window onto the Workings of Eukaryotic Posttranscriptional RNA Processing. , 1996, Journal of biomedical science.
[46] P. Gottschall,et al. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. , 1996, Neuroimmunomodulation.
[47] S. Chandler,et al. Matrix metalloproteinases degrade myelin basic protein , 1995, Neuroscience Letters.
[48] G. Hamann,et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. , 1995, Stroke.
[49] R. Bartus,et al. Calpain as a novel target for treating acute neurodegenerative disorders. , 1995, Neurological research.
[50] A. Campagnoni. Molecular Biology of Myelin Proteins from the Central Nervous System , 1988, Journal of neurochemistry.
[51] Osamu Uyama,et al. Quantitative Evaluation of Vascular Permeability in the Gerbil Brain after Transient Ischemia Using Evans Blue Fluorescence , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] F. Bloom,et al. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[53] Z. Werb,et al. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.
[54] P. Coyle,et al. Dorsal cerebral arterial collaterals of the rat , 1982, The Anatomical record.